NUSS JOHN (Chief Scientific Officer) sold 3.9% of their position (10K shares) of VENTYX BIOSCIENCES, INC. on the open market
Open‑market sale worth $326.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/7/2023ACC: 0001209191-23-048615
Officer· Chief Scientific Officer
Since Oct 2021
-10K
Net shares
Net seller
$326.0K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
10K acquired · 20K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+10K
Price / share
$0.20
Trade value
$2K
% of position
4.1%
9/5/2023
244.81K→254.81K
Common Stock
Direct
Shares
−6.99K
Price / share
$32.24
Trade value
$225.42K
% of position
2.7%
9/5/2023
254.81K→247.82K
Common Stock
Direct
Shares
−3.01K
Price / share
$33.41
Trade value
$100.54K
% of position
1.2%
9/5/2023
247.82K→244.81K
Total
Net shares
+0.00
Net value
-$323.96K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/5/2023 | M · Option Exercise | +10K | $0.20 | $2K | 4.1% | 244.81K | 254.81K |
| Common Stock Direct | 9/5/2023 | S · Sale | −6.99K | $32.24 | $225.42K | 2.7% | 254.81K | 247.82K |
| Common Stock Direct | 9/5/2023 | S · Sale | −3.01K | $33.41 | $100.54K | 1.2% | 247.82K | 244.81K |
| Total | +0.00 | -$323.96K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
10K shares
Shares
−10K
Strike price
0.20
Held after
6.78K
Exercisable
—
9/5/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock10K shares | 9/5/2023 | M · Option Exercise | −10K | 0.20 | — | 6.78K |